ACR Study Suggests Drug Lowers Breast Cancer Risk
Results of an ACR-managed study involving 110,000 women show that those who took GLP-1 medications were up to 35% less likely to develop breast cancer.
Read moreThe following statement regards the Medicare Patient Access and Practice Stabilization Act of 2024 introduced today by a bipartisan group of lawmakers. The bill would eliminate the looming proposed Medicare Physician Fee Schedule conversion factor reduction and adds an update equivalent to half of the Medicare Economic Index for 2025.
Please attribute this quote to Dana Smetherman, MD, MPH, MBA, FACR, CEO of the American College of Radiology.
"Before it adjourns at the end of the year, Congress must act on this bill to increase the conversion factor and help ensure that radiology practices and all healthcare providers can continue to offer high-quality care.
In the face of increasing costs to provide care and declining reimbursement, ACR continues to lead a physician and non-physician provider coalition to support ongoing efforts that protect patient access to care through sensible reimbursement policies.
As physician payment legislation continues to evolve, lawmakers must continue to work with the House of Medicine to enact this legislation and Medicare payment reform that stabilizes the practice environment and safeguards patient access to lifesaving care.”
ACR Study Suggests Drug Lowers Breast Cancer Risk
Results of an ACR-managed study involving 110,000 women show that those who took GLP-1 medications were up to 35% less likely to develop breast cancer.
Read moreACR Supports MARCA Bill
ACR® supports passage of the Medicare Access to Radiology Care Act. MARCA calls for Medicare payment directly to the radiologists for services in which radiologist assistants participated.
Read moreMark Alson Receives Thorwarth Award
ACR honors Mark D. Alson, MD, as the Thorwarth Award recipient for outstanding leadership and contributions to radiology health policy and economics.
Read more